• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可吸收左心耳封堵器的动物实验研究。

Animal Experimental Study of Bioabsorbable Left Atrial Appendage Occluder.

机构信息

Department of Cardiovasology, Changhai Hospital, Second Military Medical University.

Shanghai East Hospital, School of Medicine, Tongji University.

出版信息

Int Heart J. 2024 Sep 30;65(5):898-904. doi: 10.1536/ihj.23-439. Epub 2024 Sep 12.

DOI:10.1536/ihj.23-439
PMID:39261033
Abstract

Left atrial appendage (LAA) closure can prevent stroke in high-risk patients with atrial fibrillation.A bioabsorbable LAA occluder made of degradable polymer materials, such as polydioxanone (PDO) and poly-L-lactic acid (PLA), and nitinol wire was used. Occluders were successfully implanted in 18 Chinese rural dogs, 2 of which died within 48 hours after operation due to pericardial tamponade and hemorrhage, respectively. Follow-up observation was performed after transcatheter LAA closure. New tissue was found on the surface of the occluder 2 months after operation. No adjacent structures such as the mitral valve and the left superior pulmonary vein were affected by the occluder discs. Hematoxylin and eosin (HE) staining was performed at 3 months after operation, which showed intact intimal structure on the occluder surface, and unabsorbed PDO and PLA were observed. Scanning electron microscopy showed irregular arrangement of endothelial cells. New endothelial tissue was observed to completely cover the occluder at 6 months after operation. Most PDOs were replaced by fibrous connective tissue, and scanning electron microscopy showed regularly arranged endothelial cells. Pathological examination at 12 months showed only a small remnant of PDO. The gross specimens of the liver, spleen, and kidneys and pathological examination did not indicate thromboembolism.The bioabsorbable LAA occluder made of PDO, PLA, and nitinol wire was safe and effective for the occlusion of LAA in dogs. The surface of the occluder was endothelialized half a year after operation. The absorbable materials of the occluder were degraded after 1 year.

摘要

左心耳(LAA)封堵术可以预防房颤高危患者的中风。使用了一种由可降解聚合物材料(如聚二氧杂环己酮(PDO)和聚 L-乳酸(PLA))和镍钛合金丝制成的可吸收 LAA 封堵器。18 只中国农村犬成功植入封堵器,其中 2 只分别在术后 48 小时内因心包填塞和出血死亡。经导管 LAA 封堵后进行了随访观察。术后 2 个月,在封堵器表面发现了新组织。封堵器圆盘未影响相邻结构,如二尖瓣和左上肺静脉。术后 3 个月行苏木精-伊红(HE)染色,显示封堵器表面内膜结构完整,观察到未吸收的 PDO 和 PLA。扫描电子显微镜显示内皮细胞排列不规则。术后 6 个月观察到新的内皮组织完全覆盖封堵器。大多数 PDO 被纤维结缔组织取代,扫描电子显微镜显示内皮细胞排列规则。术后 12 个月的病理检查仅显示 PDO 的一小部分残余物。肝脏、脾脏和肾脏的大体标本和病理检查均未提示血栓栓塞。由 PDO、PLA 和镍钛合金丝制成的可吸收 LAA 封堵器在犬中用于 LAA 封堵是安全有效的。术后半年封堵器表面内皮化。封堵器的可吸收材料在 1 年后降解。

相似文献

1
Animal Experimental Study of Bioabsorbable Left Atrial Appendage Occluder.可吸收左心耳封堵器的动物实验研究。
Int Heart J. 2024 Sep 30;65(5):898-904. doi: 10.1536/ihj.23-439. Epub 2024 Sep 12.
2
Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.演示 StrokeShield 系统用于完全闭合和闭塞左心耳以治疗非瓣膜性心房颤动的概念验证。
PLoS One. 2021 Jun 22;16(6):e0253299. doi: 10.1371/journal.pone.0253299. eCollection 2021.
3
Transcatheter occlusion of the left atrial appendage--experimental testing of a new Amplatzer device.经导管左心耳封堵术-新型 Amplatzer 装置的实验测试。
Catheter Cardiovasc Interv. 2010 Aug 1;76(2):181-5. doi: 10.1002/ccd.22536.
4
Development and preclinical evaluation of a biodegradable ventricular septal defect occluder.可生物降解的室间隔缺损封堵器的研制及临床前评价。
Catheter Cardiovasc Interv. 2013 Feb;81(2):324-30. doi: 10.1002/ccd.24580. Epub 2012 Sep 7.
5
Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.新型间隔封堵器在术后及套索结扎术后渗漏或解剖结构不适合传统经皮封堵的患者中用于左心耳封堵的应用。
Circ Cardiovasc Interv. 2020 Oct;13(10):e009227. doi: 10.1161/CIRCINTERVENTIONS.120.009227. Epub 2020 Sep 18.
6
Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model.新型左心耳封堵器(深圳信镛医疗器械有限公司生产的LAmbre™封堵器)在犬模型中的临床前评估
Int J Cardiol. 2013 Oct 9;168(4):3996-4001. doi: 10.1016/j.ijcard.2013.06.083. Epub 2013 Jul 18.
7
Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application.使用Amplatzer房间隔封堵器进行套索术后左心耳渗漏封堵及重复套索应用的初步经验。
Heart Rhythm. 2014 Nov;11(11):1877-83. doi: 10.1016/j.hrthm.2014.06.035. Epub 2014 Jun 30.
8
Long-term follow-up after left atrial appendage occlusion with comparison of transesophageal echocardiography versus computed tomography to guide medical therapy and data about postclosure cardioversion.左心耳封堵术后的长期随访:经食管超声心动图与计算机断层扫描用于指导药物治疗的比较及封堵术后复律的数据
J Cardiovasc Electrophysiol. 2017 Oct;28(10):1140-1150. doi: 10.1111/jce.13289. Epub 2017 Jul 26.
9
Preclinical assessment of a modified Occlutech left atrial appendage closure device in a canine model.改良型Occlutech左心耳封堵装置在犬模型中的临床前评估
Int J Cardiol. 2016 Oct 15;221:413-8. doi: 10.1016/j.ijcard.2016.07.048. Epub 2016 Jul 5.
10
"One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.一站式服务:房间隔缺损封堵联合左心耳封堵治疗房间隔缺损合并心房颤动的安全性和有效性。
BMC Cardiovasc Disord. 2020 Oct 12;20(1):444. doi: 10.1186/s12872-020-01708-6.

引用本文的文献

1
Acute myocardial infarction with ventricular septal rupture: Clinical characteristics, prognosis factors, and treatment strategies.急性心肌梗死合并室间隔破裂:临床特征、预后因素及治疗策略
World J Cardiol. 2025 Jul 26;17(7):109787. doi: 10.4330/wjc.v17.i7.109787.
2
Advancing Atrial Fibrillation Research: The Role of Animal Models, Emerging Technologies and Translational Challenges.推进心房颤动研究:动物模型、新兴技术及转化挑战的作用
Biomedicines. 2025 Jan 27;13(2):307. doi: 10.3390/biomedicines13020307.